Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Weemers, Just
8  Ergebnisse:
Personensuche X
?
1

Extension of Indication for Authorised Oncology Products in..:

Mulder, Jorn ; Verjans, Robin ; Verbaanderd, Ciska...
Frontiers in Medicine.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
2

Future of the drug label: Perspectives from a multistakehol..:

Gispen‐de Wied, Christine C. ; Weemers, Just ; Boon, Wouter..
British Journal of Clinical Pharmacology.  85 (2019)  10 - p. 2442-2445 , 2019
Link: https://doi.org/10.1111/..
 
?
3

Willingness to Pay for Adverse Drug Event Regulatory Action:

Bouvy, Jacoline ; Weemers, Just ; Schellekens, Huub.
PharmacoEconomics.  29 (2011)  11 - p. 963-975 , 2011
Link: https://doi.org/10.2165/..
 
?
4

Extension of Indication for Authorised Oncology Products in..:

Mulder, Jorn ; Verjans, Robin ; Verbaanderd, Ciska...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695872/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Extension of Indication for Authorised Oncology Products in..:

Mulder, Jorn ; Verjans, Robin ; Verbaanderd, Ciska...
2296-858X.  , 2021
Link: https://dspace.library.u..
 
?
6

Future of the drug label: Perspectives from a multistakehol..:

Gispen‐de Wied, Christine C ; Weemers, Just ; Boon, Wouter..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783599/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
7

Future of the drug label:Perspectives from a multistakehold..:

Gispen-de Wied, Christine C ; Weemers, Just ; Boon, Wouter..
https://research.rug.nl/en/publications/716a971e-6d9a-4dfb-bdb1-313a1a4d720c.  , 2019
Link: https://hdl.handle.net/1..
 
?
8

Extension of Indication for Authorised Oncology Products in..:

Jorn Mulder ; Robin Verjans ; Ciska Verbaanderd...
https://www.frontiersin.org/articles/10.3389/fmed.2021.790782/full.  , 2021
Link: https://doi.org/10.3389/..
 
1-8